AstraZeneca Pharmaceuticals LP

10/17/2025 | Press release | Distributed by Public on 10/17/2025 14:12

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

AstraZeneca Pharmaceuticals LP published this content on October 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 17, 2025 at 20:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]